Director's Dealing • Jun 26, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
Washington, D.C. 20549
OMB APPROVAL
| OMB Number: | 3235-0287 |
|---|---|
| Estimated average burden hours | |
| per response | 0.5 |
Check this box if no longer subject to
Instruction 1(b).
Section 16. Form 4 or
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| 1. Name and Address of Reporting Person Nabel, M.D., Gary J. Ph.D |
2. Issuer Name and Ticker or Trading Symbol OPKO Health, Inc. [OPK] |
5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _ 10% Owner X Director Officer (give title below)_ Other (specify below) |
||
|---|---|---|---|---|
| (Last) | (First) (Middle) 4400 Biscayne Blvd. |
3. Date of Earliest Transaction (Month/Day/Year) 06/22/2022 |
X Chief Innovation Officer |
|
| (Street) Miami FL 33137 (City) (State) (Zip) |
4. If Amendment, Date Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person ____ Form filed by More than One Reporting Person |
| 1.Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
2A. Deemed Execution Date, if any |
3. Transaction Code (Instr. 8) |
or Disposed of (D) (Instr. 3, 4 and 5) |
4. Securities Acquired (A) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) |
6. Ownership Form: |
7. Nature of Indirect Beneficial |
||
|---|---|---|---|---|---|---|---|---|---|---|
| (Month/Day/Year) | Code | V | Amount | (A) or (D) |
Price | (Instr. 3 and 4) | Direct (D) or Indirect (I) (Instr. 4) |
Ownership (Instr. 4) |
||
| Common Stock | 75,471 | D | ||||||||
| Common Stock | 06/22/2022 | P | 1,491 | A | \$2.495 | 19,779,005 | I | Held by the GJN 2021 (1) TRUST |
||
| Common Stock | 06/22/2022 | P | 65,280 | A | \$2.4999 | 19,844,285 | I | Held by the GJN 2021 (1) TRUST |
||
| Common Stock | 06/22/2022 | P | 13,229 | A | \$2.5 | 19,857,514 | I | Held by the GJN 2021 |
| Common Stock | 06/22/2022 | P | 13,229 | A | \$2.5 | 19,857,514 | I | (1) TRUST |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 06/22/2022 | P | 31,023 | A | \$2.495 | 19,808,537 | I | Held by the EGN 2021 (2) TRUST |
| Common Stock | 06/22/2022 | P | 15,200 | A | \$2.4975 | 19,823,737 | I | Held by the EGN 2021 (2) TRUST |
| Common Stock | 06/22/2022 | P | 33,777 | A | \$2.5 | 19,857,514 | I | Held by the EGN 2021 (2) TRUST |
| Common Stock | 06/22/2022 | P | 80,000 | A | \$2.47 | 80,000 | I | Held by Nabel Family Investments (3) LLC |
| 1. Title of | 2. | 3. Transaction | 3A. Deemed | 4. | 5. Number | 6. Date Exercisable and | 7. Title and | 8. Price of | 9. Number of | 10. | 11. Nature | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Derivative | Conversion | Date | Execution Date, if | Transaction | of | Expiration Date | Amount of | Derivative | Derivative | Ownership | of Indirect | ||||
| Security | or Exercise | (Month/Day/Year) | any | Code | Derivative | (Month/Day/Year) | Underlying | Security | Securities | Form of | Beneficial | ||||
| (Instr. 3) | Price of | (Month/Day/Year) | (Instr. 8) | Securities | Securities | (Instr. 5) | Beneficially | Derivative | Ownership | ||||||
| Derivative | Acquired | (Instr. 3 and 4) | Owned | Security: | (Instr. 4) | ||||||||||
| Security | (A) or | Following | Direct (D) | ||||||||||||
| Disposed of | Reported | or Indirect | |||||||||||||
| (D) | Transaction(s) | (I) | |||||||||||||
| (Instr. 3, 4, | (Instr. 4) | (Instr. 4) | |||||||||||||
| and 5) | |||||||||||||||
| Amount | |||||||||||||||
| or | |||||||||||||||
| Date | Expiration | Number | |||||||||||||
| Code | V | (A) | (D) | Exercisable | Date | Title | of Shares |
Steven D. Rubin, Attorney-in-Fact 06/24/2022
**Signature of Reporting Person Date
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.